Simon Atkinson

Simon Atkinson, IUPUI Vice Chancellor for Research

 Simon Atkinson is Vice Chancellor for Research, IUPUI, and Associate Vice President for Research for Indiana University, with responsibility for industry relations and technology commercialization. Atkinson is an internationally respected National Institutes of Health-funded researcher specializing in kidney biology research. His background spans science, medicine and business, and his interactions in research and education extend far beyond his core research on kidney disease, with a record of numerous scientific collaborations with investigators across campus, especially in the Herman B Wells Center for Pediatric Research at the School of Medicine.
Atkinson first joined IU in 1994 as an assistant professor in the division of Nephrology at the School of Medicine and served as graduate advisor and director of the Ph.D. program in biomolecular imaging and biophysics from 2004 to 2010. In 2010, he was appointed professor and chair of the department of biology in the School of Science.
In recent years, Atkinson’s research team has focused on efforts to understand and treat acute kidney injury, a common and life-threatening complication in seriously ill patients, using state-of-the-art methods including multiphoton microscopy, RNA interference and gene therapy.
Atkinson is also a biomedical entrepreneur and co-founded INphoton, a customized, proprietary company that provided microscopy services and consulting for pharmaceutical and biotech companies in the preclinical phase of drug discovery and development. He and other IU investigators also developed the technology used by Rene Medical, Inc., a start-up, preclinical medical device company that targets the treatment and prevention of acute kidney injury.
Atkinson is well respected by his peers and has over 40 publications in highly respected peer-reviewed journals. In addition to NIH funding, his research has garnered foundation and industry support.
Atkinson earned his B.S. in cell and molecular biology from King’s College London and his Ph.D. in molecular biology from the University of Cambridge in England. He also served a postdoctoral fellowship at Johns Hopkins University School of Medicine.